Internationally recognized cancer biologist Joan Massagué has been named Director of the Sloan Kettering Institute. He was previously Chair of the Cancer Biology and Genetics Program at Memorial Sloan Kettering.
The study of some victims exposed to ionizing radiation from the 1986 Chernobyl nuclear power plant accident is yielding new information about how radiation-induced thyroid cancer develops.
Memorial Sloan Kettering researchers have found genetic mutations that cause some breast cancers to develop resistance to hormone therapy.
Stephen Long works to understand how proteins work by determining what they look like in three dimensions.
Memorial Sloan Kettering’s annual seminar exposes high school students and their teachers to cutting-edge scientific research.
Memorial Sloan Kettering cell biologist Emily Foley discusses her research, which is focused on improving the understanding of cell division.
Memorial Sloan Kettering researchers say a drug that acts on noncancerous, tumor-infiltrating cells might provide a new treatment option for the most common and aggressive type of brain cancer.
Memorial Sloan Kettering scientists are developing new imaging instrumentation that could enable pathologist and surgeons to collaborate more seamlessly and reduce the need for repeat surgeries.
Memorial Sloan Kettering researchers have discovered how a common bacterium can evolve to become more mobile and easier to get rid of.
A new imaging approach being investigated by Memorial Sloan Kettering researchers could provide better information about a tumor’s molecular activity, allowing for a more accurate diagnosis.